| Document Date: 2014-11-14 09:39:18
Open Document File Size: 124,50 KBShare Result on Facebook
Country United States / Costa Rica / / IndustryTerm treatment of schizoaffective disorder / treatment of HIV / bank / HCV Treatment / opioid products / / MedicalCondition hyperalgesia following use / tumor / demyelinating disease / IBD / hyperalgesia / inflammatory bowel disease / Lymphoma / opportunistic infections / Leydig cell tumor / disease / acidosis / chronic pain / psychiatric illness / rheumatoid arthritis / Crohn's disease / chronic / stroke / schizoaffective disorder / anaphylaxis / infectious / HCV / Stevens-Johnson syndrome / colitis / Crohn's / ulcerative colitis / spontaneous abortions / myocardial infarction / pulmonary / pheochromocytoma / autoimmune disease / angioedema / juvenile idiopathic arthritis / pancreatitis / psoriasis / hypersensitivity / infection / Type 2 diabetes mellitus / renal cell carcinoma / cystic fibrosis / anthrax / illness / infections / psoriatic arthritis / chronic hepatitis C / tuberculosis / / Organization Department of Health and Human Services / / Position Major / / Product levofloxacin / topiramate / acetaminophen / SPORANOX / INTELENCE / INVEGA / itraconazole / DURAGESIC / ULTRAM / tramadol hydrochloride / ULTRACET / Copegus / Ribavirin / Pegasys / DOXIL / REMICADE / TOPAMAX / Peginterferon / fentanyl / LEVAQUIN / / Region Asia-Pacific / / Technology pharmacokinetics / antibodies / Chemotherapy / pharmacodynamics / genotype / /
SocialTag |
Janssen Pharmaceutical Companies Product Due Date Status Description of Commitment or Requirement